The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index; 35 of the 59 sources its claims cite were checked for support.
Targeting β1-integrin inhibits vascular leakage in endotoxemia
Open accessAbstract
The study shows that inhibiting endothelial β1-integrin can reduce vascular leakage in murine endotoxemia.
Overview
CoChat Summary
TL;DR
Targeting β1-integrin with inhibitory antibodies or heterozygous endothelial deletion reduces LPS-induced vascular leakage in murine endotoxemia, and β1-integrin promotes endothelial contractility and permeability via ANGPT2-dependent α5β1-integrin/tensin-1 fibrillar adhesions. The findings suggest β1-integrin signaling as a potential vascular-stabilization target in pathological leak.
Key findings
- In cultured human endothelial cells, β1-integrin inhibition with mAb13 (0.1 μg⋅mL−1) prevented thrombin-induced loss of junctional VE-cadherin and monolayer permeability; thrombin increased traction force threefold, and mAb13 attenuated this increase.
- In murine LPS-induced endotoxemia, HMβ1 (2.5 mg⋅kg−1 i.p.) reduced leakage of 100-nm fluorospheres and 70-kDa dextran in tracheal and dermal vasculature, improved cardiac output by ejection fraction and fractional shortening, and remained effective when given 2 h after LPS.
- Endothelial β1-integrin silencing (96% mRNA silencing; ~10% active β1-integrin remained) or heterozygous endothelial deletion protected against inflammation-induced junction destabilization and LPS-induced vascular leakage, whereas β3-integrin silencing did not.
- Inflammatory agents induced ANGPT2-dependent formation of α5β1-integrin– and tensin-1–positive fibrillar adhesions; tensin-1 silencing prevented IL-1β–induced VE-cadherin loss, and ANGPT2 was required for α5-integrin recycling to adhesions.
Methods
- In vitro studies used primary human dermal blood microvascular ECs, HUVECs, and human pulmonary microvascular ECs stimulated with thrombin, IL-1β, or LPS; readouts included VE-cadherin/ZO-1 staining, electrical cell impedance, traction force microscopy, shRNA silencing, and immunofluorescence.
- In vivo studies used 2- to 4-mo-old male C57BL/6 mice with LPS (O55:B5, 11 mg⋅kg−1 i.p. for 16 h) endotoxemia; β1- or α4-integrin antibodies or controls were given at 2.5 mg⋅kg−1 i.p., and vascular leakage was measured with 100-nm fluorospheres or 70-kDa dextran, plus echocardiography and TEM.
- Conditional heterozygous endothelial β1-integrin deletion was tested in tamoxifen-induced Itgb1WT/fl mice; statistical comparisons used Student’s t tests or Tukey’s multiple comparison tests after ANOVA, with P < 0.05 considered significant.
Limitations
- The paper states that it does not identify the integrin alpha subunit(s) pairing with β1-integrin to promote vascular leakage in vivo, although α5-integrin was implicated in cultured ECs.
- The paper states that β1-integrin’s ubiquitous expression and versatile function may make it implausible for preventing long-term vascular leakage, and that whether αvβ5-integrin uses similar mechanisms remains to be investigated.
- Evident from the text: in vivo efficacy is shown in LPS-induced murine endotoxemia, with human data limited to cultured endothelial cells; no human clinical outcomes are reported.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
24 Valid · 1 Not valid · 12 Not checked · 108 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Furthermore, a neutralizing antibody against α4-integrin, which pairs with β1-integrin to form very late antigen-4 (VLA-4), which mediates leukocyte adhesion to the inflamed endothelium via VCAM-1 (22), did not reduce LPS-induced vascular leakage (SI Appendix, Fig. S12).”
§ Targeting β1-integrin inhibits vascular leakage in endotoxemia > Results > β1-Integrin Antibody Decreases Vascular Leakage Without Affecting Endothelial Inflammation.
What the sources say
- Supportedcites [22] Engelhardt B 1998 The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin J Clin Invest 102 2096 2105 9854045 PMC509164 source
The citation is attached to the explanation of α4-integrin–mediated adhesion, not to the LPS vascular-leakage result, which the citing sentence attributes to its own supplementary figure. The source paper’s Introduction describes α4-integrin/VCAM-1 interactions in inflammatory-cell recruitment across the blood–brain barrier, and its adhesion experiments show that anti-α4-integrin and anti-VCAM-1 antibodies reduce T-cell adhesion to stimulated brain endothelium. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A monoclonal antibody against mouse β1-integrin (HMβ1) (19) inhibited the spreading of murine ECs on fibronectin, similarly to mAb13-mediated inhibition of human ECs (SI Appendix, Fig. S7).”
§ Targeting β1-integrin inhibits vascular leakage in endotoxemia > Results > β1-Integrin Antibody Reduces Vascular Leakage in LPS-Induced Endotoxemia.
What the sources say
- Supportedcites [19] Carlson TR Hu H Braren R Kim YH Wang RA 2008 Cell-autonomous requirement for beta1 integrin in endothelial cell adhesion, migration and survival during angiogenesis in mice Development 135 2193 2202 18480158 PMC2582018 source
The citation immediately follows “HMβ1,” identifying the antibody rather than sourcing the spreading result, which the citing sentence assigns to its SI Appendix figure. In “Cell adhesion, spreading, migration and focal contact formation” (page unavailable), the source lists HMβ1-1 as an anti-β1-integrin antibody used in its endothelial-cell experiments. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“By contrast, β3-integrin (shβ3) silencing decreased VE-cadherin in BECs, in line with previous studies (9, 15), and shβ3 did not prevent the thrombin-induced loss of VE-cadherin (Fig. 2 C and D and SI Appendix, Fig. S3A).”
§ Targeting β1-integrin inhibits vascular leakage in endotoxemia > Results > Inflammatory Agents Decrease Endothelial Monolayer Integrity via β1-Integrin.
What the sources say
- Could not verifycites [9] Su G 2012 Absence of integrin αvβ3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation Am J Respir Crit Care Med 185 58 66 21980034 PMC3262039 sourceExperimental — accuracy not yet measured
The Results report that αvβ3-blocking antibodies increased agonist-induced permeability in human endothelial cells, but do not report β3 silencing in BECs or a decrease in VE-cadherin. Searches for VE-cadherin and cadherin found no passage addressing that outcome. (LLM, conf=0.76)
- Could not verifycites [15] Hakanpaa L 2015 Endothelial destabilization by angiopoietin-2 via integrin β1 activation Nat Commun 6 5962 25635707 PMC4316742 sourceExperimental — accuracy not yet measured
In Results and Discussion, “Integrin-mediated regulation of actin cytoskeleton” reports that β3-integrin silencing disorganized cortical actin in BECs, but does not report its effect on VE-cadherin. “Tie2 silencing reduces endothelial monolayer integrity” reports reduced junctional VE-cadherin after Tie2 silencing, not β3-integrin silencing. Searches for β3 silencing and VE-cadherin found no passage establishing the claimed link. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“inflammatory agents increased staining for the scaffold protein tensin-1, whose binding site in β1-integrin overlaps with that of talin-1 (24, 25), thus marking the central adhesions as fibrillar adhesions”
§ Targeting β1-integrin inhibits vascular leakage in endotoxemia > Results > Inflammatory Agents Promote α5β1-Integrin Translocation into Tensin-1–Positive Fibrillar Adhesions in an ANGPT2-Dependent Manner.
What the sources say
- Partly supportedcites [24] Pankov R 2000 Integrin dynamics and matrix assembly: Tensin-dependent translocation of alpha(5)beta(1) integrins promotes early fibronectin fibrillogenesis J Cell Biol 148 1075 1090 10704455 PMC2174533 sourceExperimental — accuracy not yet measured
The Discussion describes tensin-enriched ECM contacts that move toward the cell center and associate with fibronectin fibrils, supporting tensin as a marker of these fibrillar contacts. The paper does not report inflammatory agents increasing tensin-1 staining or establish that tensin and talin-1 have overlapping β1-integrin binding sites. (LLM, conf=0.86)
- Supportedcites [25] Georgiadou M 2017 AMPK negatively regulates tensin-dependent integrin activity J Cell Biol 216 1107 1121 28289092 PMC5379951 source
The citation is attached to the statement that tensin binds β1-integrin at a site overlapping a talin-binding site. The Discussion explicitly states this, and the Results describe tensin1 enrichment in centrally located fibrillar adhesions. The citing authors' observation that inflammatory agents increased staining is not attributed to this source. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“We previously showed that, in addition to TIE2, ANGPT2 can signal via α5β1-integrin, leading to destabilization of EC monolayers where TIE2 levels are low (15).”
§ Targeting β1-integrin inhibits vascular leakage in endotoxemia > Discussion
What the sources say
- Supportedcites [15] Hakanpaa L 2015 Endothelial destabilization by angiopoietin-2 via integrin β1 activation Nat Commun 6 5962 25635707 PMC4316742 source
The Results and Discussion section ('Ang2, but not Ang1, activates β1-integrin'; page not provided) reports that Ang2 activates endogenous α5β1 integrin. The Abstract reports that Ang2-mediated β1-integrin activation destabilizes Tie2-silenced endothelial monolayers, matching the claim's low-Tie2 condition. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
89 more claims · 1 with their cited sources checked
Create a free account to see all 145 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 35
- The quote only partly states this claim. 1
Citations
Cites
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570 · cited 1×
“In line with this conclusion, transgenic overexpression of ANGPT2 in mice leads to aberrant and decreased EC-basement membrane matrix interactions (27, 28).”
BackgroundEvolving functions of endothelial cells in inflammation
Pober, J. S., & Sessa, W. C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2171 · Cited by 2,022 · cited 3×
“translocation of alpha(5)beta(1) integrins promotes early fibronectin fibrillogenesis.”
BackgroundCell adhesion: integrating cytoskeletal dynamics and cellular tension
Parsons, J. T., Horwitz, A. R., & Schwartz, M. A. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2957 · Cited by 1,988 · cited 1×
“In focal adhesions, integrins connect to the actin cytoskeleton and cellular signaling pathways through linker and adapter proteins, such as paxillin, talin, vinculin, and α-actinin (8).”
BackgroundWhy have clinical trials in sepsis failed?
Marshall, J. C. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.01.007 · Cited by 805 · cited 2×
“The underlying molecular mechanisms behind pathological capillary leakage remain incompletely understood, hindering the development of targeted therapies aimed at vascular stabilization (3).”
BackgroundExcess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in Humans
Parikh, S. M., Mammoto, T., Schultz, A., Yuan, H.-T., Christiani, D., Karumanchi, S. A., & Sukhatme, V. P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030046 · Cited by 527 · cited 2×
“Furthermore, the EC-derived growth factor angiopoietin-2 (ANG2, ANGPT2), which is up-regulated in diseases associated with inflammation and vascular leakage, synergizes with multiple inflammatory agents, promoting endothelial permeability (6, 7).”
BackgroundIntegrin Dynamics and Matrix Assembly
Pankov, R., Cukierman, E., Katz, B.-Z., Matsumoto, K., Lin, D. C., Lin, S., Hahn, C., & Yamada, K. M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.5.1075 · Cited by 482 · cited 2×
“Instead, inflammatory agents increased staining for the scaffold protein tensin-1, whose binding site in β1integrin overlaps with that of talin-1 (24, 25), thus marking the central adhesions as fibrillar adhesions (Fig.”
BackgroundBroken Barriers: A New Take on Sepsis Pathogenesis
Goldenberg, N. M., Steinberg, B. E., Slutsky, A. S., & Lee, W. L. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002011 · Cited by 324 · cited 2×
“A burst in the generation of proinflammatory agents, as a part of an overwhelmed host response, contributes to endothelial barrier breakdown in these diseases, promoting shock and multiorgan failure in patients (1, 2).”
BackgroundEndothelial destabilization by angiopoietin-2 via integrin β1 activation
Hakanpaa, L., Sipila, T., Leppanen, V.-M., Gautam, P., Nurmi, H., Jacquemet, G., Eklund, L., Ivaska, J., Alitalo, K., & Saharinen, P. (2015) · Nature Communications · doi:10.1038/ncomms6962 · Cited by 287 · cited 4×
“β1-integrin, which is the major integrin subunit expressed by ECs (11, 12, 15), was simultaneously inhibited with β1-integrin antibody (mAb13).”
BackgroundResultInfluentialSelf-citationTie1 controls angiopoietin function in vascular remodeling and inflammation
Korhonen, E. A., Lampinen, A., Giri, H., Anisimov, A., Kim, M., Allen, B., Fang, S., D’Amico, G., Sipilä, T. J., Lohela, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84923 · Cited by 283 · cited 2×
“This correlated with loss of ANGPT2 agonist activity and increased vascular leakage (21, 23).”
BackgroundMethodSelf-citation
Cited by
TrackMate 7: integrating state-of-the-art segmentation algorithms into tracking pipelines
Ershov, D., Phan, M.-S., Pylvänäinen, J. W., Rigaud, S. U., Le Blanc, L., Charles-Orszag, A., Conway, J. R. W., Laine, R. F., Roy, N. H., Bonazzi, D., et al. (2022) · Nature Methods · doi:10.1038/s41592-022-01507-1 · Cited by 1,201
Self-citationRole of Angiopoietin-2 in Vascular Physiology and Pathophysiology
Akwii, R. G., Sajib, M. S., Zahra, F. T., & Mikelis, C. M. (2019) · Cells · doi:10.3390/cells8050471 · Cited by 543
Integrin trafficking in cells and tissues
Moreno-Layseca, P., Icha, J., Hamidi, H., & Ivaska, J. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0223-z · Cited by 464
Self-citationThe effects of sepsis on endothelium and clinical implications
Dolmatova, E. V., Wang, K., Mandavilli, R., & Griendling, K. K. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa070 · Cited by 317
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
Smadja, D. M., Mentzer, S. J., Fontenay, M., Laffan, M. A., Ackermann, M., Helms, J., Jonigk, D., Chocron, R., Pier, G. B., Gendron, N., et al. (2021) · Angiogenesis · doi:10.1007/s10456-021-09805-6 · Cited by 200
Metadata
- Authors
- Hakanpaa, L., Kiss, E. A., Jacquemet, G., Miinalainen, I., Lerche, M., Guzmán, C., Mervaala, E., Eklund, L., Ivaska, J., & Saharinen, P.
- Affiliations
- Translational Cancer Biology Program, Research Programs Unit, Biomedicum Helsinki, University of Helsinki, FI-00014 Helsinki, Finland;
- University of Helsinki (FI)
- Åbo Akademi University (FI)
- University of Oulu (FI)
- Corresponding author
- Saharinen, Pipsa
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2018-06-25
- Volume
- 115
- Issue
- 28
- Pages
- E6467-E6476
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC6048499
- OpenAlex
- W2810667939
- Cited by
- 95
- References
- 35
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 14 · 2023: 7 · 2022: 12 · 2021: 18 · 2020: 19 · 2019: 9 · 2018: 2
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- UTUPub (University of Turku) (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- Åbo Akademi University Research Portal (submittedVersion)
- Funders
- Helsingin Yliopisto
- Turun Yliopisto
- Syöpäjärjestöt
- Helsinki Institute of Life Science, Helsingin Yliopisto
- Biocenter, University of Oulu (251314)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- beta1 integrin, angiopoietin-2, vascular leakage, endotoxemia, endothelial barrier function, lipopolysaccharide, VE-cadherin, endothelial junctions, alpha5beta1 integrin, integrin signaling, sepsis, heart failure, stress fibers
- MeSH terms
- Cadherin 5, Animals, Disease Models, Animal, Intercellular Junctions, Lipopolysaccharides, Mice, Transgenic, Antigens, CD, Cadherins, Integrin beta1, Endotoxemia, Protein Transport, Integrin alpha5beta1, Endothelial Cells, Receptor, TIE-2, Mice, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting β1-integrin inhibits vascular leakage in endotoxemia. https://app.cochat.ai/papers/10.1073/pnas.1722317115
- The paper
- Hakanpaa, L., Kiss, E. A., Jacquemet, G., Miinalainen, I., Lerche, M., Guzmán, C., Mervaala, E., Eklund, L., Ivaska, J., & Saharinen, P. (2018). Targeting β1-integrin inhibits vascular leakage in endotoxemia. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1722317115
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.